Population pharmacokinetic (PopPK) and exposure-response (ER) modeling of cabozantinib (C) in patients (pts) with renal cell carcinoma (RCC) in the phase 3 METEOR study Meeting Abstract
| Authors: | Lacy, S.; Hutmacher, M. M.; Yang, B.; Motzer, R. J.; Escudier, B. J.; Powles, T.; Choueiri, T. K.; Miles, D.; Nielsen, J. |
| Abstract Title: | Population pharmacokinetic (PopPK) and exposure-response (ER) modeling of cabozantinib (C) in patients (pts) with renal cell carcinoma (RCC) in the phase 3 METEOR study |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 130s |
| Language: | English |
| ACCESSION: | WOS:000404665403164 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.2565 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2565-- Source: Wos |
